Inicio › Enfermedades de los pulmones › Ohio
Ensayos clínicos de Enfermedades de los pulmones en Ohio
18 estudios sobre Enfermedades de los pulmones buscan participantes en Ohio.
Ciudades en Ohio
Texto oficial del estudio (inglés)
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
- University of Cincinnati Cancer Center, Cincinnati
- The Ohio State University, Columbus
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT06765109A Study of COVID-19 Vaccine(s) in Children and Adults
- Dayton Clinical Research, Dayton
- Senders Pediatrics, South Euclid
ReclutandoFase 3Se aceptan voluntarios sanos
Edades de 5 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07798648A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- University of Cincinnati Medical Center, Cincinnati
- University of Cincinnati College of Medicine (UC Holmes), Cincinnati
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07013474A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Remington-Davis, Inc, Columbus
ReclutandoFase 3
Edades de 12 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06679140American Lung Association (ALA) Lung Health Cohort
- Ohio State University, Columbus
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 25 a 35 · Todos los sexos · Actualizado el 23 sept 2026 · NCT04543461A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Toledo Institute of Clinical Research Inc., Toledo
ReclutandoFase 2
Edades de 18 a 70 · Todos los sexos · Actualizado el 22 sept 2026 · NCT06977581A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Miami Valley Hospital South, Centerville
- USO - Oncology Hematology Care, Cincinnati
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 sept 2026 · NCT06119581A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
- Gabrail Cancer and Research Center, Canton
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 1 sept 2026 · NCT05967689Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Columbus
- Research Site, Toledo
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 ago 2026 · NCT05624450A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
- Research Site, Cincinnati
ReclutandoFase 2
Edades de 4 a 11 · Todos los sexos · Actualizado el 27 ago 2026 · NCT07525375A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 104, Cleveland
ReclutandoFase 3
Edades de 18 a 80 · Todos los sexos · Actualizado el 11 ago 2026 · NCT07555483Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
- University of Cincinnati Medical Center, Cincinnati
- Ohio State University Comprehensive Cancer Center, Columbus
ReclutandoFase 2
Edades de 18 a 70 · Todos los sexos · Actualizado el 26 jun 2026 · NCT04614103A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
- University of Cincinnati, Cincinnati
ReclutandoFase 1/2
Edades de 18 a 70 · Todos los sexos · Actualizado el 11 jun 2026 · NCT05361174A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- The Ohio State University Wexner Medical Center, Columbus
ReclutandoFase 1/2
Edades de 12 en adelante · Todos los sexos · Actualizado el 27 may 2026 · NCT03093116Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 19 feb 2026 · NCT02984761A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Oncology Hematology Care Clinical Trials, LLC, Cincinnati
- Cleveland Clinic, Cleveland
- The Ohio State University Comprehensive Cancer Center, Columbus
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 dic 2025 · NCT06619561Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
- Ohio Health, Columbus
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2025 · NCT04555161Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
- The Ohio State University Wexner Medical Center, Columbus
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 jul 2024 · NCT02735707De ClinicalTrials.gov, datos obtenidos el 2 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.